Noir Dove - Commercial Diagnostic Consulting for B2B Founders

Revenue Exists.
Scaling Does Not.

The gap is almost always between your teams, not between you and the market.

For B2B founders at $1M ARR and above. Marketing, sales, and product are operating without a shared understanding of who they are selling to and why those buyers buy. We find the specific point where that breaks down, build the strategy to fix it, and align your team to run it.

Founders we have worked with

Past $1M ARR, Founders Become the Only People Holding their Commercial System Together

Founders walk in thinking the problem is execution. It is almost always the structure.

Marketing runs campaigns. Sales works leads. Product ships features. Pipeline stays flat. The founder spends 15 to 20 hours a week translating between teams, sitting in deals the sales team should be closing, and explaining the product in ways no one else can yet replicate.

MARKETING

Generates leads sales cannot close

MQLs that miss the decision-maker entirely. Marketing optimises for the ICP it was given in year one. Sales is pitching to a different buyer. Neither team has noticed.

SALES

Closes on promises product has not shipped

Reps win deals by committing to roadmap features. Customers churn at month six when the product does not match the pitch. The renewal conversation never had a chance.

PRODUCT

Builds for the customer who complains, not the one who expands

Enterprise customers with the most Slack threads set the roadmap. The buyers who would pay more and refer others never get a seat at the table.

FOUNDER

Still in every important deal at $3M ARR

The team cannot close without the founder in the room. Every quarter of this costs a month of product time, fundraising bandwidth, or the next key hire.

Noir Dove is a Commercial Consulting Firm.
Our Every Engagement Starts with Diagnosis.

We work with B2B founders at $1M ARR and above whose growth has decelerated and who have already tried the obvious fixes. Content agency, new sales hire, product pivot. None of it compounded. We go into your pipeline, your team conversations, your CRM, & your customer calls. We find the specific point where your commercial motion is breaking and build the strategy your team runs for the next twelve months.

Diagnosis before strategy

Without a diagnosis, strategy is a guess. We have seen founders spend $200K on positioning work built on the wrong ICP. We run the diagnostic first.

Strategy before execution

Running campaigns before the strategy is confirmed burns $5K to $15K a month on the wrong audience. We confirm the strategy first.

Alignment before growth

Sales and marketing operating on different ICP definitions is the most common reason pipeline stays flat despite headcount growth. We align the functions before scaling anything.

Execution in the right sequence

We help with execution. Only after diagnosis, strategy, and alignment are confirmed. If a founder asks us to run campaigns before that, we decline.

The sequence is not optional. Each step depends on the one before it.

B2B Founders' Core Challenges

Founders walk in with a theory. Half the time, it is wrong.

Our experts thrive on a potent blend of cutting-edge technology, scientific precision, data insights, and a healthy dose of good old-fashioned hard work. This fusion empowers us to craft and deliver email marketing campaigns that truly resonate, engage, and drive remarkable results for our clients. Noir Dove email marketing agency is a science lab for your innovative campaigns.

ICP THAT DRIFTED AFTER LAUNCH

The product evolved. The buyer definition did not. Marketing and sales are still targeting year-one customers while the best buyers in year three look completely different. The drift goes unnoticed until churn arrives at month 12.

ICP · BUYING FRICTION

Marketing hits its lead targets every quarter. Sales says the leads are wrong. Both are correct. Marketing is optimising for a buyer that sales has moved away from.

CROSS-FUNCTIONAL ALIGNMENT

Sales closes by promising features not yet built. Churn arrives at month six when the product does not match the pitch. The renewal conversation was already lost at the close.

PIPELINE · REVENUE INTEGRITY

The narrative lands with practitioners. The CISO, the CTO, or the economic buyer who signs the contract needs a different conversation and is not getting it.

POSITIONING · MESSAGING

Customers leave at month 6 or 12. Product attributes it to gaps in the roadmap. In most cases the gap was in the sale: the buyer was sold a future the product was not ready to deliver.

CONVERSION SIGNAL ANALYSIS

The sales team has been hired and ramped. Every deal above $20K still needs the founder in the room. The team cannot replicate the pitch because the pitch was never written down.

COMMERCIAL SCALABILITY

The loudest enterprise customer sets the quarterly roadmap. The buyers who would expand ARR and refer peers never have a seat at the planning table.

COMMERCIAL SCALABILITY

Deals take 6 to 18 months. The team cannot tell which ones are real and which are polite stalls. Forecasting is a guess. Pipeline coverage means nothing.

CONVERSION SIGNAL ANALYSIS

Strong traction in home market. US pilots run. Nothing closes. US enterprise buyers need proof formats, reference structures, and entry narratives that differ from every other market.

ICP DEPTH · MARKET NARRATIVE

We Have Fixed this Breakdown for
SaaS, Cybersecurity, Healthtech, and AI Founders.

B2B SaaS, cybersecurity, healthtech, and AI companies stall for the same underlying reason: the commercial motion was never formally built. The first $1M to $3M came from founder relationships and product fit. Scaling past it requires something that was never designed.

CYBERSECURITY SAAS & MSSPS

CISOs get 200+ pitches a year. Most vendors sound identical.

Procurement involves legal, IT, and the board. Each layer needs a different conversation. Technical founders build one narrative for everyone and wonder why deals stall in procurement.

B2B SAAS

The ICP that closed the first $1M is rarely the right buyer at $3M.

Most teams do not notice the drift until churn arrives at month 12. By then, marketing has built an audience around the wrong persona and sales has optimised its pitch for the wrong pain.

HEALTHTECH & DIGITAL HEALTH

Clinical & administrative buyers are different. Most pitches treat them as one.

A founder who built for the clinical buyer pitches to the procurement director. The procurement director forwards it to legal. Nothing moves. The founder thinks the product is the problem.

AI-NATIVE & AI-ENABLED FIRMS

Buyers are skeptical of AI capability claims. AI founders struggle.

Decision-makers have been burned by demos that did not reflect production reality. Narratives built around what the model can do lose to narratives built around what the buyer’s team will be able to do differently.

What We Promise (Solutions We Deliver)

4-6

Weeks starting engagement

7

Commercial dimensions examined

4

Documents every client receives

2

Founders in every engagement

50+

Countries worth of growth patterns experienced

"You'll have a unified team, a clear GTM plan, and a predictable engine for long-term growth."

- Gaurav Sabharwal

Founder and CEO, Joy of Performing (JOP)

Gaurav Sabharwal - Founder & CEO - JOP - NoirDove Testimonial

CEO, B2B SaaS | $2.1M ARR

"We had been calling it a product problem for two years. It was a positioning problem."

Founder, Sales Tech | $3.4M ARR

"Our ICP had drifted and nobody had named it. The root cause map was the document we needed eighteen months earlier."

Co-Founder, Fintech SaaS | $1.9M ARR

"The Diagnostic found the gap between what we thought we sold and what our sales team actually pitched."

Client names withheld by mutual agreement. Sector and ARR range confirmed. References available on request.

Two founders.
One way of working.

Both founders are in every engagement. The diagnostic is not delegated to an inexperienced professional. Sakshi and Jagsir review every application personally before the engagement starts.

Sakshi is direct and structured. Founders who work with her leave knowing exactly what is broken, why it developed, and what has to change first. She makes the diagnosis actionable. Every recommendation comes with a sequence and a reason for the sequence.

Co-Founder & CEO

Jagsir creates the conditions where founders tell the truth about their business. Real commercial problems surface only when founders feel safe enough to name them. Every recommendation he brings stays grounded in what the team can carry forward without external support.

Co-Founder & CMO

Tech at the Core

Deep tech insights and scalable agentic automation.

Outcome-Obsessed

Every initiative ties directly to revenue or growth velocity.

Proven Track

Built GTM engines from zero, delivered compounding growth.

Trusted Partner

Dedicated growth experts guide the AI quarterly.

Frequently Asked Questions (FAQs)

Founders often carry the weight of scattered GTM efforts-bursts of activity, inconsistent messaging, and a pipeline that rises and falls without rhythm. Noir Dove steps in to replace that unpredictability with a calm, structured GTM foundation that compounds month after month.

Instead of running behind campaigns, your company enters a steady growth pattern where positioning, narrative, and revenue motions fall into place naturally. The noise reduces. The direction becomes clear. The entire GTM begins working in unison, consistently, quietly, and powerfully.

Noir Dove creates a space where you no longer feel you’re rebuilding your GTM every quarter. Instead, momentum carries forward on its own, giving founders a predictable engine they can trust.

Predictability does not come from intensity; it comes from alignment. When positioning, messaging, and revenue paths all come together coherently, your GTM starts compounding organically.

Noir Dove offers the following:

  • ⁠A clear and consistent narrative
  • Demand signals that no longer fluctuate
  • Alignment across marketing, product, and sales
  • A GTM rhythm that removes guesswork

Growth ceases to be a push and starts to feel more like a natural progression-one propelled by clarity, structure, and compounding motions.

Yes. But automation starts only after the GTM foundation is healthy.

Noir Dove does a calm diagnostic before any single workflow is created to understand where prospects drop, what slows the deals, and where friction hides inside your CRM and funnel. It is after the gaps are clear that automation begins.

What follows is not a set of random workflows but a clean, structured system through which buyers seamlessly move along:

  • CRM setups that stay clean, intuitive, and orderly
  • Intelligent routing that removes manual tasks
  • Workflows that maintain momentum without quarterly resets
  • ⁠Reporting layers that provide clarity, not clutter

The result is straightforward:

Your GTM doesn’t restart; it compounds. Automation moves prospects along while you focus on the decisions that matter.

Brand positioning really works when it perfectly aligns what customers need with what your product actually delivers. Most startups feel that their messaging is strong, but in reality, prospects often lose the narrative halfway and miss the value.

That gap is where revenue leaks quietly, and that is exactly where Noir Dove enters the picture.

Noir Dove bridges the gap between what customers expect and your product’s reality. Using a serene, organized process:

  • ⁠Your story is clarified and unmistakable
  • ⁠Your value becomes easy to understand
  • ⁠Your story is consistent across every touchpoint
  • ⁠Buyers finally understand why your offering matters to them.

Founders often describe this as the moment when everything “clicks.”

Once Noir Dove takes over the narrative, your customers don’t just hear your story, they understand it, remember it, and trust it.

This clarity shortens sales cycles, strengthens conversions, and creates predictable movement from awareness → trust → revenue.

When the message becomes unmistakable, customers stop guessing. They start choosing. 

Not necessarily. Noir Dove can act as your GTM backbone: building systems, setting direction, and developing a framework your team can then manage with ease in time. If you already have a team, the GTM engine amplifies their performance.

If you don’t, Noir Dove becomes the steady hand that keeps progress consistent and predictable. Either way, the system is yours, never dependent on continuous outside support.

Growth does not Compound When the Structure Underneath it is Broken.

A structured diagnosis finds it. A commercial strategy fixes it. The first conversation costs nothing.

Every application is reviewed personally by Sakshi and Jagsir.